Ling Xu

4.3k total citations
123 papers, 3.2k citations indexed

About

Ling Xu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ling Xu has authored 123 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 55 papers in Oncology and 33 papers in Cancer Research. Recurrent topics in Ling Xu's work include Cell death mechanisms and regulation (12 papers), Cancer-related molecular mechanisms research (11 papers) and Lung Cancer Treatments and Mutations (8 papers). Ling Xu is often cited by papers focused on Cell death mechanisms and regulation (12 papers), Cancer-related molecular mechanisms research (11 papers) and Lung Cancer Treatments and Mutations (8 papers). Ling Xu collaborates with scholars based in China, United States and Australia. Ling Xu's co-authors include Xiujuan Qu, Yunpeng Liu, Kezuo Hou, Xiaofang Che, Jinglei Qu, Ce Li, Ye Zhang, Yibo Fan, Lina Shen and Yongtai Zhang and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ling Xu

120 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ling Xu China	34	1.8k	1.0k	764	421	351	123	3.2k
Shengtao Yuan China	33	2.0k 1.1×	675 0.7×	1.1k 1.4×	472 1.1×	400 1.1×	116	3.5k
Zhi Shi China	42	2.4k 1.3×	1.6k 1.5×	635 0.8×	335 0.8×	454 1.3×	122	4.3k
Xian‐Jun Qu China	37	2.1k 1.2×	943 0.9×	987 1.3×	550 1.3×	229 0.7×	133	3.9k
Yan Ji United States	32	1.3k 0.7×	704 0.7×	378 0.5×	373 0.9×	383 1.1×	114	2.9k
Venkateshwar G. Keshamouni United States	31	2.0k 1.1×	800 0.8×	698 0.9×	627 1.5×	476 1.4×	49	3.5k
Kyung‐Hee Chun South Korea	37	2.5k 1.4×	717 0.7×	1.0k 1.3×	707 1.7×	208 0.6×	80	3.5k
Seung Hyun Oh South Korea	30	1.4k 0.8×	402 0.4×	440 0.6×	243 0.6×	228 0.6×	100	2.6k
Saverio Candido Italy	31	2.2k 1.2×	1.1k 1.1×	996 1.3×	528 1.3×	442 1.3×	80	3.7k
Sanjeev K. Srivastava United States	35	2.1k 1.2×	980 1.0×	1.4k 1.8×	461 1.1×	260 0.7×	62	3.4k
Yingjie Yu United States	31	2.0k 1.1×	946 0.9×	720 0.9×	150 0.4×	170 0.5×	63	3.2k

Countries citing papers authored by Ling Xu

Since Specialization

Citations

This map shows the geographic impact of Ling Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Xu more than expected).

Fields of papers citing papers by Ling Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Xu. The network helps show where Ling Xu may publish in the future.

Co-authorship network of co-authors of Ling Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Xu. A scholar is included among the top collaborators of Ling Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Xu. Ling Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cheng, Yu, Jin Wang, Na Song, et al.. (2024). Genetic feature diversity of KRAS-mutated colorectal cancer and the negative association of DNA mismatch repair deficiency relevant mutational signatures with prognosis. Genes & Diseases. 12(1). 101245–101245.

Zou, Yuxia, Huanhuan Zhang, Yuenan Wang, et al.. (2023). Efficacy and safety of durvalumab + chemotherapy vs. atezolizumab + chemotherapy in the treatment of small-cell lung cancer: a retrospective comparative cohort study. Journal of Thoracic Disease. 15(6). 3339–3349. 10 indexed citations

Liu, Yang, et al.. (2021). Development and Validation of a Prognostic Nomogram for Gastric Signet Ring Cell Carcinoma: A Multicenter Population-Based Study. Frontiers in Oncology. 11. 603031–603031. 10 indexed citations

Xu, Ling, et al.. (2020). Hepatocellular carcinoma and multiple myeloma with elevated globulin: a case report and literature review. Journal of International Medical Research. 48(5). 1220719947–1220719947. 2 indexed citations

Zhang, Yi, F Yin, Ling Xu, et al.. (2020). Comparative Efficacy of Drugs for the Treatment of Chronic Constipation. Journal of Clinical Gastroenterology. 54(10). e93–e102. 4 indexed citations

Li, Yangfang, et al.. (2018). An analysis of ovarian tumors in elderly women. Zhonghua laonian yixue zazhi. 37(8). 898–900. 1 indexed citations

Xu, Ling, Xiujuan Qu, Xuejun Hu, et al.. (2018). β‐elemene increases the sensitivity of gastric cancer cells to TRAIL by promoting the formation of DISC in lipid rafts. Cell Biology International. 42(10). 1377–1385. 19 indexed citations

Wen, Ti, Zhenning Wang, Yi Li, et al.. (2017). A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer. Cancer Immunology Research. 5(7). 524–534. 46 indexed citations

Zhang, Ye, Xiujuan Qu, Xiaofang Che, et al.. (2017). miR‐200a enhances TRAIL‐induced apoptosis in gastric cancer cells by targeting A20. Cell Biology International. 42(5). 506–514. 24 indexed citations

10.

Xu, Ling, et al.. (2016). Use of GPS Data to Analyze Urban Bus Travel Time Variability In China. Transportation Research Board 95th Annual MeetingTransportation Research Board. 1 indexed citations

11.

Li, Heming, Ling Xu, Ce Li, et al.. (2014). Ubiquitin ligase Cbl-b represses IGF-I-induced epithelial mesenchymal transition via ZEB2 and microRNA-200c regulation in gastric cancer cells. Molecular Cancer. 13(1). 136–136. 72 indexed citations

12.

Chen, Zhiwei, Bin Liu, Yunhua Xu, et al.. (2014). FBXL5-mediated degradation of single-stranded DNA-binding protein hSSB1 controls DNA damage response. Nucleic Acids Research. 42(18). 11560–11569. 29 indexed citations

13.

Qu, Xiujuan, Yibo Fan, Xiaofang Che, et al.. (2013). Trastuzumab and oxaliplatin exhibit a synergistic antitumor effect in HER2-postive gastric cancer cells. Anti-Cancer Drugs. 25(3). 315–322. 12 indexed citations

14.

Zhang, Guodong, Jing Liu, Ye Zhang, et al.. (2012). Cbl‐b‐dependent degradation of FLIP_L is involved in ATO‐induced autophagy in leukemic K562 and gastric cancer cells. FEBS Letters. 586(19). 3104–3110. 18 indexed citations

15.

Xu, Ling, Ye Zhang, Jing Liu, et al.. (2012). TRAIL-activated EGFR by Cbl-b-regulated EGFR redistribution in lipid rafts antagonises TRAIL-induced apoptosis in gastric cancer cells. European Journal of Cancer. 48(17). 3288–3299. 47 indexed citations

16.

Wang, Juyong, Rui-Xin Zhang, Changsheng Dong, et al.. (2012). Topical treatment with Tong-Luo-San-Jie gel alleviates bone cancer pain in rats. Journal of Ethnopharmacology. 143(3). 905–913. 17 indexed citations

17.

Xu, Ling, Qingwen Sun, Songmin Jiang, et al.. (2012). Changes in gene expression profiles of the hip joint ligament of patients with ankylosing spondylitis revealed by DNA chip. Clinical Rheumatology. 31(10). 1479–1491. 12 indexed citations

18.

Zhang, Lingyun, Yuee Teng, Ye Zhang, et al.. (2011). C-Src-mediated RANKL-induced breast cancer cell migration by activation of the ERK and Akt pathway. Oncology Letters. 3(2). 395–400. 44 indexed citations

19.

Liu, Jing, Ye Zhang, Jinglei Qu, et al.. (2011). β-Elemene-induced autophagy protects human gastric cancer cells from undergoing apoptosis. BMC Cancer. 11(1). 183–183. 119 indexed citations

20.

Chu, Min, Ronald Mierzwa, Ling He, et al.. (2001). Structure of Sch 528647: A New Antitumor Antibiotic Related to Fumagillin.. The Journal of Antibiotics. 54(12). 1096–1099. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact